Today: 9 June 2026
Wuhan project breaks ground: ESWIN Material (688783) stock in focus before Monday’s China open
1 February 2026
2 mins read

Wuhan project breaks ground: ESWIN Material (688783) stock in focus before Monday’s China open

Shanghai, Feb 1, 2026, 09:55 GMT+8 — Market closed.

  • On Friday, shares ended at 26.29 yuan, slipping 0.79%.
  • A government-linked report confirmed that ESWIN’s silicon wafer facility in Wuhan has begun construction following approval of a key project filing.
  • Investors face a tough call: a major capacity expansion looms while the company continues to predict losses.

The Hubei Province Department of Economy and Information Technology reported that Xi’an ESWIN Material Technology Co., Ltd. Class A has kicked off construction on its Wuhan silicon wafer base. This costly expansion might influence sentiment when A-shares resume trading on Monday.

Timing is crucial. Large wafer projects often shift forecasts on production, client acquisitions, and funding—particularly for newer STAR Market entrants still ramping up. Investors want to know if this signals real momentum or merely increased spending.

On Jan. 21, the company forecasted 2025 revenue around 2.65 billion yuan, with a net loss to shareholders near 738 million yuan—about the same as last year. It pointed to sluggish pass-through of recovering end-demand, a second plant still ramping up, and hefty fixed costs plus R&D expenses as drivers of the losses. Still, it highlighted that operating cash net inflow remained positive.

ESWIN shares ended Friday at 26.29 yuan, slipping 0.79% from the previous close of 26.50. During the session, the stock fluctuated between 25.71 and 26.98 yuan, according to data.

Zhidian Caijing said the project cleared its first-phase filing, a key registration step in China’s investment approvals, and construction is underway with an estimated 2.5 billion yuan investment. The report also noted that the project entities have been registered in Optics Valley.

The Wuhan facility was initially mentioned in a Dec. 2 company announcement linked to a deal with Wuhan Optics Valley Semiconductor Industrial Investment Co., Ltd. ESWIN revealed the project aims to produce 12-inch silicon single-crystal polished wafers and epitaxial wafers — which include an extra grown layer used in specific chip manufacturing steps — targeting logic and memory chips as well as other devices.

The company revealed plans to reach a capacity of at least 500,000 wafers per month, aiming to boost its total output to roughly 1.7 million wafers monthly once the expansion wraps up.

ESWIN’s ticker carries a “-U” suffix, a STAR Market marker for firms that went public ahead of profitability, per Shanghai Stock Exchange rules. SSE

In notes from a Dec. 25 investor meeting, ESWIN outlined a “15-year” strategy focused on establishing “2–3” manufacturing hubs for advanced 12-inch wafer fabs. Yang Chunlei and Wang Chen were named as company representatives present. Dfcfw PDF

The report also noted that ESWIN’s second factory aims to hit a monthly output of 500,000 wafers by the end of 2026, with consolidated profitability targeted for 2027.

The downside is clear-cut: wafer demand could drop sharply, prices might remain stubbornly high, and major builds risk delays due to equipment delivery, customer qualification, or financing hurdles. Such a large project could also ramp up leverage if the cash burn continues.

Traders are eyeing Monday’s open in China to see if the construction start signals actual progress or spells new capex risk — and to catch any updates on financing details or the project timeline.

Stock Market Today

  • WisdomTree Launches Space Economy ETF Amid Rising Thematic Demand
    June 9, 2026, 10:37 AM EDT. WisdomTree has launched the WisdomTree Space Economy UCITS ETF (WSPC), targeting companies in space-related technologies and services, with a 0.50% expense ratio. The ETF, listed on multiple European exchanges, tracks an index focused on launches, commercial space, defence, and emerging tech. This reflects the shift from government-led space exploration to a commercial ecosystem, including satellite connectivity and climate monitoring. Investor interest in space tech is growing, highlighted by Seraphim Space Investment Trust's near 200% share rise. WisdomTree now manages $10.9 billion in thematic ETFs, with $3.3 billion net inflows in 2026, underscoring increasing demand for specialised thematic investment strategies.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Longsys Electronics stock set for Monday test after profit jump forecast and a sharp Friday drop
Previous Story

Longsys Electronics stock set for Monday test after profit jump forecast and a sharp Friday drop

SSE share price flat at 2,422p as a key trading update looms this week
Next Story

SSE share price flat at 2,422p as a key trading update looms this week

Go toTop